Skip to main content

CORRECTION article

Front. Oncol., 09 February 2023
Sec. Breast Cancer
Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1154441

Corrigendum: HER-2 positive primary neuroendocrine neoplasms of the breast with signet ring feature: A case report and review of literature

This article is a correction to:

  1. HER-2-positive primary neuroendocrine neoplasms of the breast with signet ring feature: A case report and review of literature

    1. Read original article
Yunjin Li,Yunjin Li1,2Yi Cao,Yi Cao1,2Xiaoying WuXiaoying Wu2Ruijie Liu*Ruijie Liu2*Kuansong Wang,*Kuansong Wang1,2*
  • 1Department of Pathology, School of Basic Medical Sciences, Central South University, Changsha, Hunan, China
  • 2Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan, China

A Corrigendum on
HER-2-positive primary neuroendocrine neoplasms of the breast with signet ring feature: A case report and review of literature

By Li Y, Cao Y, Wu X, Liu R and Wang K (2022) Front. Oncol. 12:1029007. doi: 10.3389/fonc.2022.1029007

Incorrect Affiliation

In the published article, there was an error in affiliation(s) [1]. Instead of “Ruijie Liu1 *”, it should be “Ruijie Liu2 *”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: neuroendocrine neoplasm, signet ring feature, breast cancer, HER-2 positive, review

Citation: Li Y, Cao Y, Wu X, Liu R and Wang K (2023) Corrigendum: HER-2 positive primary neuroendocrine neoplasms of the breast with signet ring feature: A case report and review of literature. Front. Oncol. 13:1154441. doi: 10.3389/fonc.2023.1154441

Received: 30 January 2023; Accepted: 31 January 2023;
Published: 09 February 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Li, Cao, Wu, Liu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Kuansong Wang, wangks001@csu.edu.cn; Ruijie Liu, 250748401@qq.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.